Maternal Vascular Malperfusion and Anatomic Cord Abnormalities Are Prevalent in Pregnancies With Fetal Congenital Heart Disease

被引:0
|
作者
Carreon, Chrystalle Katte [1 ,2 ]
Ronai, Christina [3 ,4 ]
Hoffmann, Julia K. [5 ,6 ]
Tworetzky, Wayne [3 ,4 ]
Morton, Sarah U. [3 ,5 ]
Wilkins-Haug, Louise E. [7 ,8 ]
机构
[1] Boston Childrens Hosp, Dept Pathol, Boston, MA USA
[2] Harvard Med Sch, Dept Pathol, Boston, MA USA
[3] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA
[4] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA
[5] Boston Childrens Hosp, Dept Pediat, Div Newborn Med, Boston, MA 02115 USA
[6] Ludwig Maximilians Univ Munchen, Dept Pediat Cardiol & Pediat Intens Care, Munich, Germany
[7] Brigham & Womens Hosp, Div Maternal Fetal Med & Reprod Genet, Boston, MA 02115 USA
[8] Harvard Med Sch, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
DEFECTS; CITED2; GROWTH; TRANSPOSITION; PREECLAMPSIA; PATTERNS; PLACENTA; LESIONS; RISK;
D O I
10.1002/pd.6650
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Objective: Impairments in the maternal-fetal environment are associated with adverse postnatal outcomes among infants with congenital heart disease. Therefore, we sought to investigate placental anomalies as they related to various forms of fetal congenital heart disease (FCHD). Methods: We reviewed the placental pathology in singleton pregnancies with and without FCHD. FCHD was divided into separate categories (transposition physiology, obstructive left, obstructive right, biventricular without obstruction, and others). Exclusion criteria included other prenatally known structural malformations and/or aneuploidy. The significance threshold was set at p < 0.05 or False Discovery rate q < 0.05 when multiple tests were performed. Results: The cohort included 215 FCHD and 122 non-FCHD placentas. FCHD placentas showed increased rates of maternal vascular malperfusion (24% vs. 5%, q < 0.001) and cord anomalies (27% vs. 1%, q < 0.001). Placentas with fetal TGA demonstrated a lower rate of hypoplasia when compared with other FCHD types (1/39 vs. 51/176, Fisher's exact p = 0.015). Conclusion: Placental maternal vascular malperfusion is increased in FCHD. The prevalence of vascular malperfusion did not differ by FCHD type, indicating that CHD type does not predict the likelihood of placental vascular dysfunction. Further investigation of the placental-fetal heart axis in FCHD is warranted given the importance of placental health.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Vascular malperfusion and abruption are prevalent in placentas from pregnancies with congenital heart disease and not associated with cardiovascular risk
    Altendahl, Marie
    Mok, Thalia
    Adimkpayah, Ekene
    Goldstein, Jeffrey
    Lin, Jeannette
    Afshar, Yalda
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [2] Vascular malperfusion and abruption are prevalent in placentas from pregnancies with congenital heart disease and not associated with cardiovascular risk
    Marie Altendahl
    Thalia Mok
    Ekene Adimkpayah
    Jeffrey Goldstein
    Jeannette Lin
    Yalda Afshar
    [J]. Scientific Reports, 13
  • [3] Placental vascular malperfusion lesions in fetal congenital heart disease
    Leon, Rachel L.
    Sharma, Kavita
    Mir, Imran N.
    Herrera, Christina L.
    Brown, Steven L.
    Spong, Catherine Y.
    Chalak, Lina F.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 227 (04) : 620.e1 - 620.e8
  • [4] Evidence of maternal vascular malperfusion in placentas of women with congenital heart disease
    Rodriguez-Soto, Ana E.
    Pham, Donna
    Tran, Tracy
    Meads, Morgan
    Stanley, Valentina
    Melber, Dora
    Lamale-Smith, Leah
    Zhang-Rutledge, Kathy
    Rakow-Penner, Rebecca
    Alshawabkeh, Laith
    Parast, Mana M.
    Contijoch, Francisco
    [J]. PLACENTA, 2022, 117 : 209 - 212
  • [5] Small for gestational age is not associated with maternal vascular malperfusion in congenital heart disease
    Altendahl, Marie
    Mok, Thalia
    Adinkpayah, Ekene
    Goldstein, Jeffrey
    Lin, Jeannette
    Afshar, Yalda
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 228 (01) : S358 - S359
  • [6] FREQUENCY AND PATTERN OF PLACENTAL ABNORMALITIES IN PREGNANCIES WITH FETAL CONGENITAL HEART DISEASE
    O'Hare, Clare
    Edmunds, Miranda
    Gu, Hongjie
    He, Mai
    Ortinau, Cynthia M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 474 - 474
  • [7] SEVERE MATERNAL MORBIDITY IN PREGNANCIES COMPLICATED BY FETAL CYANOTIC CONGENITAL HEART DISEASE
    Anderson, Shae
    DeFranco, Emily
    Rossi, Robert
    Divanovic, Allison
    Cnota, James
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 634 - 634
  • [8] Congenital fetal heart disease - course and outcome of pregnancies
    Plesinac, Sneana
    Plecas, Darko
    Ljubic, Aleksandar
    Parezanovic, Vojislav
    Terzic, Milan
    [J]. CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2007, 2 (02): : 203 - 207
  • [9] Placental fetal vascular malperfusion in congenital diaphragmatic hernia
    Stanek, Jerzy
    [J]. VIRCHOWS ARCHIV, 2024, 484 (01) : 83 - 91
  • [10] The association between severe fetal congenital heart defects and placental vascular malperfusion lesions
    Miremberg, Hadas
    Gindes, Liat
    Schreiber, Letizia
    Sternfeld, Alona Raucher
    Bar, Jacob
    Kovo, Michal
    [J]. PRENATAL DIAGNOSIS, 2019, 39 (11) : 962 - 967